Skimmed Milk Powder Market Size & Growth: The skimmed milk powder market is projected to grow at a CAGR of 6.69% to reach a market size of US$45.518 billion by 2030 from US$32.926 billion in 2025, according to a new report by Knowl...
Skimmed Milk Powder Market Size & Growth:
The skimmed milk powder market is projected to grow at a CAGR of 6.69% to reach a market size of US$45.518 billion by 2030 from US$32.926 billion in 2025, according to a new report by Knowledge Sourcing Intelligence. The skimmed milk powder market is driven by the growing demand for low-fat and fat-free dairy products due to the rising number of health-conscious consumers. Its demand is also driven by the confectionery and bakery industry for its light dairy flavour. The long shelf life offered by skimmed milk is appealing to the growing, busy modern lifestyle consumers. Alongside, the market is driven by the increasing use of skimmed milk in infant formulas. The market is witnessing increasing fortification of the skimmed milk with vitamins, minerals and functional ingredients to enhance its nutritional profile to compete with the fortified plant-based alternatives. At the same time, the market is witnessing a shift towards lactose-free formulations to target the lactose-intolerant customers. The market is also increasing its focus on product formulation with natural flavors to cater to younger consumers and kids The organic trend is impacting this market as well. There is a growing demand from customers for organic skimmed milk. Alongside, market players are increasing the concentration of protein to cater to the wellness and fitness market. During the forecasted period, the market is anticipated to witness an increasing use of Ultra-High Temperature processing techniques for longer shelf-life. ? View a sample of the report or purchase the complete study at: Skimmed Milk Powder Market ReportSkimmed Milk Powder Market Report Highlights:
- The market is driven by rising demand from the health-conscious population and rising demand for confectionery and bakery products. Growing use in infant formulas, urbanization and rising disposable income are driving the market.
- The market is shifting towards increased fortification of skimmed milk with minerals, vitamins, and there is a shift towards increasing the protein concentration.
- The market is witnessing a shift towards lactose-free formulations to cater to lactose-intolerant customers.
- There is a rising demand for organic and clean-label formulations due to the growing sustainability trend and increasing demand for organic products.
- Europe holds a considerable share of the market due to its high dairy culture, growing health focus and increasing demand from the bakery sector, while Asia-Pacific will be growing at a high rate, driven by increasing demand for infant formulas, high population and a growing health-conscious population.
Skimmed Milk Powder Market Segmentation:
Knowledge Sourcing Intelligence has segmented the global Skimmed Milk Powder Market based on product type, application, packaging, distribution channel, and region: Skimmed Milk Powder Market, By Product Type- Cow Milk Powder
- Black Skim Milk Powder
- White Skim Milk Powder
- Green Skim Milk Powder
- Oolong Skim Milk Powder
- Bakery Products
- Confectionery
- Nutritional Foods
- Infant Formula
- Frozen Desserts
- Dry Mixes
- Loose Skim Milk Powder
- Bagged Skim Milk Powder
- Instant Skim Milk Powder
- Bottled & Canned Skim Milk Powder
- Supermarkets & Hypermarkets
- Convenience Stores
- Online
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Others
- Middle East and Africa (MEA)
- South Arabia
- UAE
- Others
- Asia Pacific
- Japan
- China
- India
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
Skimmed Milk Powder Market Key Players:
- Nestle
- Dairy America
- Alpen Dairies
- Nova Dairy products
- Amul
- Arla Foods amba
- Olam International
- Dana Dairy Group
- Darigold
- Fonterra Co-operative Group
- Lactalis Ingredients
- Royal FrieslandCampina N.V.
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.
